Key Events This Week
Jan 21: Stock hits upper circuit amid strong buying pressure
Jan 22: Another upper circuit hit with increased delivery volumes
Jan 23: Sharp decline to lower circuit amid heavy selling pressure
Week Close: Rs.9.35 (-0.43%) vs Sensex -3.31%

Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-23 13:00:14Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 23 Jan 2026, hitting its lower circuit limit and registering a maximum daily loss of 2.55%. The stock’s sharp decline reflects mounting investor concerns amid deteriorating technical and fundamental indicators.
Read full news article
Lasa Supergenerics Ltd Hits Upper Circuit Amid Strong Buying Pressure
2026-01-22 11:00:15Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in buying interest on 22 Jan 2026, hitting its upper circuit price limit. Despite recent underperformance relative to its sector and broader market indices, the stock’s sudden rally underscores intense demand and a potential shift in investor sentiment.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-01-22 10:10:41Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-14 11:00:08Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 14 Jan 2026, hitting its lower circuit limit amid intense selling pressure. The stock closed at ₹9.43, down 4.46% on the day, marking its fifth consecutive day of losses and signalling mounting investor concerns.
Read full news article
Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-12 13:00:24Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 12 Jan 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The share price plunged by nearly 5%, marking its maximum daily loss and signalling panic selling among investors amid subdued market sentiment.
Read full news articleLasa Supergenerics Ltd Falls 3.53%: 2 Key Events Shaping the Week
2026-01-10 13:01:27
Key Events This Week
5 Jan: Stock opens at Rs.10.92, down 3.62%
7 Jan: Hits upper circuit amid strong buying pressure
9 Jan: Hits lower circuit amid heavy selling pressure
9 Jan: Week closes at Rs.10.93, down 3.53%

Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-09 13:00:10Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 9 Jan 2026, hitting its lower circuit limit and registering a maximum daily loss of 4.8%. The stock’s sharp decline reflects mounting investor concerns amid falling participation and unfilled supply, signalling a period of heightened volatility and bearish sentiment.
Read full news articleLasa Supergenerics Limited - Updates
05-Dec-2019 | Source : NSELasa Supergenerics Limited has informed the Exchange regarding 'we have been granted patents for our key products the period of 20 years from the date of Filing'.
Lasa Supergenerics Limited - Corrigendum
27-Nov-2019 | Source : NSELasa Supergenerics Limited has informed the Exchange regarding Corrigendum to detailed public statement published on September 06, 2019 for the attention of equity shareholders of company.
Lasa Supergenerics Limited - Updates
26-Nov-2019 | Source : NSELasa Supergenerics Limited has informed the Exchange regarding 'Letter of Offer'.
Corporate Actions
13 Feb 2026
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available







